James E. Levine's Net Worth

$742 Thousand

Estimate Recalculated Sep 13, 2024 10:29PM EST

Who is James E. Levine

James E. Levine does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cidara Therapeutics, Inc., Cardiff Oncology, Inc., and VERENIUM CORP.

SEC CIK

James E. Levine's CIK is 0001463151

Past Insider Trading and Trends

2021 was James E. Levine's most active year for acquiring shares with 7 total transactions. James E. Levine's most active month to acquire stocks was the month of August. 2013 was James E. Levine's most active year for disposing of shares, totalling 11 transactions. James E. Levine's most active month to dispose stocks was the month of September. 2009 saw James E. Levine paying a total of $82,400.00 for 361,666 shares, this is the most they've acquired in one year. In 2013 James E. Levine cashed out on 464,490 shares for a total of $436,664.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cidara Therapeutics, Inc.

Chief Financial Officer
Updated Mar 19, 2021
Form 4
130.00K
Mar 19, 2021
249.80K
Grant
Mar 17
Form 4
50.00K
$2.01
$100.72K
Nov 12, 2020
115.83K
Purchase
Nov 10
Form 4
365.94%
135.00K
Mar 23, 2020
171.89K
Options
Mar 19
Form 4/A
30.00K
$1.91
$57.24K
Mar 23, 2020
30.00K
Purchase
Sep 24
Form 4
$2.51
$17.30K
Jan 30, 2020
211.89K
Options
Jan 28
Form 4
17.14%
30.00K
$1.91
$57.24K
Sep 26, 2019
205.00K
Purchase
Sep 24
Form 4
175.00K
Dec 04, 2018
175.00K
Grant
Dec 03
Form 3
Dec 04, 2018
Showing 8 results

Cardiff Oncology, Inc.

Chief Financial Officer
Updated Mar 07, 2024
Form 4
27.06%
205.01K
Mar 07, 2024
962.50K
Grant
Mar 07
Form 4
35.26%
197.47K
Mar 16, 2023
757.49K
Grant
Mar 15
Form 4
100.00%
30.00K
$1.56
$46.71K
Sep 19, 2022
60.00K
Purchase
Sep 16
Form 4
43.59%
170.02K
Mar 10, 2022
560.02K
Grant
Mar 09
Form 4
30.00K
$6.47
$194.00K
Sep 13, 2021
30.00K
Purchase
Sep 10
Form 4
390.00K
Jul 12, 2021
390.00K
Grant
Jul 12
Form 3
Jul 12, 2021
Showing 7 results

VERENIUM CORP

President & CEO
Updated Nov 04, 2013
Form 4
-100.00%
-464.49K
$4.00
-$436.66K
Nov 04, 2013
Disposition
Oct 31
Form 4
35.00K
Aug 02, 2013
35.00K
Grant
Aug 01
Form 4
30.00K
$4.23
$126.90K
Aug 03, 2012
30.00K
Grant
Aug 02
Form 4
4.79%
4.99K
$3.65
$18.23K
May 16, 2012
109.17K
Purchase
May 15
Form 4
31.58%
25.00K
$3.18
$79.50K
Aug 29, 2011
104.17K
Purchase
Aug 25
Form 4
46.15%
25.00K
$1.69
$42.25K
Aug 16, 2011
79.17K
Purchase
Aug 12
Form 4
164.49K
Mar 01, 2011
164.49K
Grant
Feb 24
Form 4
85.00K
Sep 09, 2010
85.00K
Grant
Sep 07
Form 4
1,200.34%
50.01K
$2.51
$125.27K
Aug 17, 2010
54.17K
Purchase
Aug 13 - Aug 16
Form 4/A
20.83K
May 19, 2010
20.83K
Grant
Nov 12
Form 4
20.00K
$4.12
$82.40K
Dec 15, 2009
20.00K
Grant
Dec 11
Form 4
Nov 16, 2009
20.83K
Acq/Dis
Nov 12
Form 4
300.00K
May 27, 2009
300.00K
Grant
May 06
Form 3
May 07, 2009
Showing 14 results